Document is current
Any future updates will be listed below
-
Authors
Wang, Zongjie https://orcid.org/0000-0001-9900-7197
Kelley, Shana O. https://orcid.org/0000-0003-3360-5359
- License Information
-
More Information
Article History
Received: 17 March 2024
Accepted: 31 October 2024
First Online: 14 February 2025
Competing interests
: Z.W. and S.O.K. are co-founders of CTRL Therapeutics, which is commercializing microfluidic technologies for cellular therapy. S.O.K. has received research funds from Amgen and Moderna outside of the submitted work.
